Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review of the treatment options for epilepsy in tuberous sclerosis complex: towards precision medicine
Susanne Schubert‐Bast, Adam Strzelczyk
Therapeutic Advances in Neurological Disorders (2021) Vol. 14
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies
Adam Strzelczyk, Susanne Schubert‐Bast
CNS Drugs (2022) Vol. 36, Iss. 10, pp. 1079-1111
Open Access | Times Cited: 95
Recent advances in pharmacotherapy for epilepsy
Amanda W. Pong, Kevin J. Xu, Pavel Klein
Current Opinion in Neurology (2023) Vol. 36, Iss. 2, pp. 77-85
Closed Access | Times Cited: 40
Impact of Genetic Testing on Therapeutic Decision-Making in Childhood-Onset Epilepsies—a Study in a Tertiary Epilepsy Center
Allan Bayat, Christina Fenger, Tanya Ramdal Techlo, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 4, pp. 1353-1367
Open Access | Times Cited: 28
Recent Advances in Pharmacologic Treatments of Drug-Resistant Epilepsy: Breakthrough in Sight
Pavel Klein, Daniel Friedman, Patrick Kwan
CNS Drugs (2024) Vol. 38, Iss. 12, pp. 949-960
Closed Access | Times Cited: 5
Evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex: A review and treatment algorithm
Debopam Samanta
Epilepsy & Behavior (2024) Vol. 161, pp. 110123-110123
Closed Access | Times Cited: 5
Autism spectrum disorder and a possible role of anti-inflammatory treatments: experience in the pediatric allergy/immunology clinic
Harumi Jyonouchi
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 4
Therapeutic Approaches to Tuberous Sclerosis Complex: From Available Therapies to Promising Drug Targets
Elena Conte, Brigida Boccanegra, Giorgia Dinoi, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1190-1190
Open Access | Times Cited: 4
mTOR signaling: A pivotal player in Treg cell dysfunction in systemic lupus erythematosus
Xingyun Zhao, Shifen Wang, Shengjun Wang, et al.
Clinical Immunology (2022) Vol. 245, pp. 109153-109153
Closed Access | Times Cited: 18
Altered cortical excitability in tuberous sclerosis and the effect of mTOR inhibitors: An intracranial electrical stimulation study
Kishore Vedala, Gewalin Aungaroon, David M. Ritter, et al.
Clinical Neurophysiology (2025) Vol. 172, pp. 1-9
Closed Access
The clinical interface of tuberous sclerosis complex and autism spectrum disorder: insights and future directions
R. Ramani, B Fatima, Anower Hussain, et al.
Neurological Sciences (2025)
Closed Access
Characterization of immune cell profiles in the blood of children and adults with tuberous sclerosis complex disease
Laura Bierhansl, Lisa Langenbruch, Andreas Schulte‐Mecklenbeck, et al.
Journal of the Neurological Sciences (2025), pp. 123465-123465
Closed Access
Insights into Tuberous Sclerosis Complex : From Genes to Clinics
Soo Yeon Kim
Journal of Korean Neurosurgical Society (2025) Vol. 68, Iss. 3, pp. 321-337
Open Access
Tuberous Sclerosis Complex: An updated in the treatment of epilepsy for early careers
Kette D. Valente, Letícia Pereira de Brito Sampaio, Silvia Vincentiis, et al.
Epilepsy & Behavior (2025) Vol. 167, pp. 110396-110396
Closed Access
Treatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions
Avantika Singh, Aristides Hadjinicolaou, Jurriaan M. Peters, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 733-748
Open Access | Times Cited: 9
Entry of cannabidiol into the fetal, postnatal and adult rat brain
Georgia Fitzpatrick, Yifan Huang, Fiona Qiu, et al.
Cell and Tissue Research (2024) Vol. 396, Iss. 2, pp. 177-195
Open Access | Times Cited: 3
Paradigm shift in the treatment of tuberous sclerosis: Effectiveness of everolimus
Roberto Previtali, Giorgia Prontera, Enrico Alfei, et al.
Pharmacological Research (2023) Vol. 195, pp. 106884-106884
Open Access | Times Cited: 7
Identification of hub genes significantly linked to tuberous sclerosis related-epilepsy and lipid metabolism via bioinformatics analysis
Wang Weiliang, Ren Yinghao, Hou Weiliang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales
C Burke, Catriona Crossan, Emma Tyas, et al.
PharmacoEconomics - Open (2024) Vol. 8, Iss. 4, pp. 611-626
Open Access | Times Cited: 2
Health-related quality of life in children and adolescents with tuberous sclerosis complex and their caregivers: A multicentre cohort study from Germany
Laurent M. Willems, Susanne Schubert‐Bast, Janina Grau, et al.
European Journal of Paediatric Neurology (2021) Vol. 35, pp. 111-122
Closed Access | Times Cited: 14
Epidemiology and disease burden of tuberous sclerosis complex in France: A population‐based study based on national health insurance data
Francis Fagnani, Caroline Laurendeau, Marie de Zélicourt, et al.
Epilepsia Open (2022) Vol. 7, Iss. 4, pp. 633-644
Open Access | Times Cited: 8
Clinical profile of tuberous sclerosis complex patients with and without epilepsy: a need for awareness for early diagnosis
Conceição Campanário da Silva Pereira, F. D. G. Dantas, Maria Luíza Giraldes de Manreza
Arquivos de Neuro-Psiquiatria (2022) Vol. 80, Iss. 10, pp. 1004-1010
Open Access | Times Cited: 8
Efficacy, Retention Rate, and Influencing Factors of Ketogenic Diet Therapy in Children with Refractory Epilepsy: A Retrospective Study
Jue Shen, Tiejia Jiang, Feng Gao, et al.
Neuropediatrics (2022) Vol. 54, Iss. 01, pp. 037-043
Closed Access | Times Cited: 7
Therapeutic outcome of patients with Lennox–Gastaut syndrome with mitochondrial respiratory chain complex I deficiency
Jihoon Na, Young‐Mock Lee
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
The emotional burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy: A qualitative study in Japan
Michael LoPresti, Ataru Igarashi, Yaoki Sonohara, et al.
Epilepsy & Behavior (2024) Vol. 158, pp. 109932-109932
Open Access | Times Cited: 1
CRISPR-Cas9-Mediated Correction of TSC2 Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 2
Gongbo Guo, Morgan Moser, Lincoln Chifamba, et al.
The CRISPR Journal (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top